Synopsis
Synopsis
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-diphenylmethoxy-n,n-dimethylethylamine
2. Allerdryl
3. Benadryl
4. Benhydramin
5. Benylin
6. Benzhydramine
7. Citrate, Diphenhydramine
8. Dimedrol
9. Diphenhydramine
10. Diphenhydramine Citrate
11. Diphenhydramine Citrate (1:1)
12. Diphenylhydramin
13. Diphenylhydramine
14. Dormin
15. Hydrochloride, Diphenhydramine
1. 147-24-0
2. Diphenhydramine Hcl
3. Dimedrol
4. Allergival
5. Carphenamine
6. Bendylate
7. Carphenex
8. Cathejell
9. Denydryl
10. Diphamine
11. Eldadryl
12. Fenylhist
13. Noctomin
14. Ambenyl
15. Felben
16. Prodryl
17. Bena
18. Diphenhydramine.hcl
19. Diphenhydramine (hydrochloride)
20. Allergan
21. Benylin
22. Dibenil
23. Hydramine
24. Paradryl
25. Restamin
26. Silphen
27. Vicks Formula 44
28. Beldin
29. Benzhydramine Hydrochloride
30. Diphen
31. Belix
32. Dobacen Hydrochloride
33. Dimedrol Hydrochloride
34. Benzantin Hydrochloride
35. Difenhydramine Hydrochloride
36. 2-(benzhydryloxy)-n,n-dimethylethanamine Hydrochloride
37. Benzantin
38. Dimedrolum
39. Diphenylhydramine Hydrochloride
40. Nci-c56075
41. Ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-, Hydrochloride
42. 2-(benzhydryloxy)-n,n-dimethylethylamine Hydrochloride
43. Mfcd00012479
44. Diphenhydramine Hcl (benadryl)
45. 2-(diphenylmethoxy)-n,n-dimethylethylamine Hydrochloride
46. N-(2-diphenylmethoxyethyl)-n,n-dimethylamine Hydrochloride
47. Nsc-33299
48. Tc2d6jad40
49. Mls000028428
50. 2-benzhydryloxy-n,n-dimethylethanamine;hydrochloride
51. 147-24-0 (hcl)
52. Sedopretten
53. Halbmond
54. Histacyl
55. Smr000058353
56. Wehydryl
57. Resmin
58. Vena
59. Dsstox_cid_537
60. Sekundal-d
61. 2-diphenylmethoxy-n,n-dimethylethylamine Hydrochloride
62. Beta-dimethylaminoethyl Benzhydryl Ether Hydrochloride
63. Dsstox_rid_75646
64. Dsstox_gsid_20537
65. Alpha-hydroxydiphenylmethane-beta-dimethylaminoethyl Ether Hydrochloride
66. Diphenhydramine Hydrochloride 100 Microg/ml In Acetonitrile
67. Dipjemhist
68. 2-[(diphenylmethyl)oxy]-n,n-dimethylethanamine Hydrochloride
69. Banophen
70. Asdrin
71. Benadryl Preservative Free
72. Chebi:4637
73. Sk-diphenhydramine
74. Sleep-eze-3
75. Benadryl Hydrochloride
76. Ccris 2383
77. Sr-01000003069
78. Ncgc00015335-09
79. Cas-147-24-0
80. Einecs 205-687-2
81. Nsc 33299
82. Unii-tc2d6jad40
83. Tylenol Pm Tablets/caplets
84. Tylenol Cold Night Time Liquid
85. Antitussive Agents
86. Benadryl (tn)
87. Prestwick_177
88. Bayer Select Night Time Pain Relief
89. Component Of Caladryl
90. Benadril Hydrochloride
91. Benzhydrol, Beta-dimethylaminoethyl Ether Hydrochloride
92. Dimedrol-hydrochloride
93. Difenidramina Cloridrato
94. Cpd000058353
95. Opera_id_152
96. Component Of Bena-fedrin
97. Dimethylamine Benzhydryl Ester Hydrochloride
98. Diphenhydramine Hydrochloride [usp:ban:jan]
99. Diphenhydramine Hydrochloride Preservative Free
100. Cloridrato De Difenidramina
101. Diphenydramine Hydrochloride
102. Chembl1620
103. Regid_for_cid_8980
104. Schembl17071
105. Mls000758216
106. Mls001148114
107. Mls001423951
108. Mls002222180
109. Spectrum1500256
110. Dtxsid4020537
111. Hy-b0303a
112. Diphenhydramine Hydrochloride,(s)
113. Diphenhydramine Hcl [inci]
114. Hms1568m11
115. Hms1920i06
116. Pharmakon1600-01500256
117. Bcp13546
118. Nsc33299
119. Tox21_112991
120. Tox21_201472
121. Tox21_300611
122. Tox21_500377
123. Ccg-39755
124. Nsc756729
125. S1866
126. Akos005287308
127. Ac-3449
128. Lp00377
129. Nc00060
130. Nsc-756729
131. Ncgc00024414-05
132. Ncgc00093809-01
133. Ncgc00093809-02
134. Ncgc00093809-03
135. Ncgc00093809-04
136. Ncgc00093809-05
137. Ncgc00254264-01
138. Ncgc00259023-01
139. Ncgc00261062-01
140. As-12088
141. Diphenhydramine Hydrochloride (jp17/usp)
142. Diphenhydramine Hydrochloride [mi]
143. Sy010546
144. 2-benzhydryloxy-n,n-dimethylethanamine Hcl
145. Diphenhydramine Hydrochloride [jan]
146. Wln: 1n1 & 2oyr & R & Gh
147. 4-acetoxy-3,5-dimethoxybenzoicacid
148. D0423
149. Diphenhydramine Hydrochloride [mart.]
150. Diphenhydramine Hydrochloride [vandf]
151. Eu-0100377
152. Ft-0652576
153. Sw198731-2
154. Diphenhydramine Hydrochloride [usp-rs]
155. Diphenhydramine Hydrochloride [who-dd]
156. Diphenhydramine Hydrochloride, >=98% (hplc)
157. C07784
158. D 3630
159. D00669
160. Diphenhydramine Hydrochloride, Analytical Standard
161. N-(2-diphenylmethoxyethyl)-n,n-dimethylamine Hcl
162. Diphenhydramine Hydrochloride [ep Impurity]
163. Diphenhydramine Hydrochloride [orange Book]
164. Diphenhydramine Hydrochloride [ep Monograph]
165. Diphenhydramine Hydrochloride [usp Monograph]
166. Q-201003
167. Sr-01000003069-2
168. 2-(benzhydryloxy)-n,n-dimethylethanaminehydrochloride
169. 2-benzhydryloxy-n,n-dimethylethanamine;hydron;chloride
170. 2-diphenylmethoxy-n,n-dimethylethanamine Hydrochloride
171. Q26841258
172. Sr-01000003069-10
173. .beta.-dimethylaminoethyl Benzhydryl Ether Hydrochloride
174. 2-(benzhydryloxy)-n,n-dimethylethan-1-amine Hydrochloride
175. Ethylamine,n-dimethyl-2-(diphenylmethoxy)-, Hydrochloride
176. Diphenhydramine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
177. Ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-, Hydrochloride (1:1)
178. .alpha.-hydroxydiphenylmethane-.beta.-dimethylaminoethyl Ether Hydrochloride
179. Diphenhydramine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
180. Diphenhydramine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
181. Diphenhydramine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
182. 8052-21-9
183. Diphenhydramine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
184. Diphenhydramine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 291.8 g/mol |
---|---|
Molecular Formula | C17H22ClNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 291.1389920 g/mol |
Monoisotopic Mass | 291.1389920 g/mol |
Topological Polar Surface Area | 12.5 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Diphenhydramine hydrochloride |
Drug Label | Diphenhydramine Hydrochloride is an antihistamine drug having the chemical name 2-(diphenylmethoxy)-N, N-dimethylethylamine hydrochloride. It occurs as a white, odorless crystalline powder and is freely soluble in water and alcohol. The structural fo... |
Active Ingredient | Diphenhydramine hydrochloride |
Dosage Form | Elixir; Injectable; Capsule |
Route | Injection; Oral |
Strength | 50mg/ml; 50mg; 12.5mg/5ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; Mylan Institutional; Pharm Assoc; App Pharms; Barr |
2 of 4 | |
---|---|
Drug Name | Diphenhydramine hydrochloride preservative free |
Active Ingredient | Diphenhydramine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Bd Rx |
3 of 4 | |
---|---|
Drug Name | Diphenhydramine hydrochloride |
Drug Label | Diphenhydramine Hydrochloride is an antihistamine drug having the chemical name 2-(diphenylmethoxy)-N, N-dimethylethylamine hydrochloride. It occurs as a white, odorless crystalline powder and is freely soluble in water and alcohol. The structural fo... |
Active Ingredient | Diphenhydramine hydrochloride |
Dosage Form | Elixir; Injectable; Capsule |
Route | Injection; Oral |
Strength | 50mg/ml; 50mg; 12.5mg/5ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; Mylan Institutional; Pharm Assoc; App Pharms; Barr |
4 of 4 | |
---|---|
Drug Name | Diphenhydramine hydrochloride preservative free |
Active Ingredient | Diphenhydramine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Bd Rx |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Sleep Aids, Pharmaceutical
Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Diphenhydramine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphenhydramine Hydrochloride, including repackagers and relabelers. The FDA regulates Diphenhydramine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphenhydramine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diphenhydramine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diphenhydramine Hydrochloride supplier is an individual or a company that provides Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) or Diphenhydramine Hydrochloride finished formulations upon request. The Diphenhydramine Hydrochloride suppliers may include Diphenhydramine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Diphenhydramine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diphenhydramine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Diphenhydramine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Diphenhydramine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diphenhydramine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Diphenhydramine Hydrochloride USDMF includes data on Diphenhydramine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphenhydramine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diphenhydramine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Diphenhydramine Hydrochloride Drug Master File in Japan (Diphenhydramine Hydrochloride JDMF) empowers Diphenhydramine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Diphenhydramine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Diphenhydramine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Diphenhydramine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diphenhydramine Hydrochloride Drug Master File in Korea (Diphenhydramine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diphenhydramine Hydrochloride. The MFDS reviews the Diphenhydramine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Diphenhydramine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diphenhydramine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diphenhydramine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diphenhydramine Hydrochloride suppliers with KDMF on PharmaCompass.
A Diphenhydramine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Diphenhydramine Hydrochloride Certificate of Suitability (COS). The purpose of a Diphenhydramine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diphenhydramine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diphenhydramine Hydrochloride to their clients by showing that a Diphenhydramine Hydrochloride CEP has been issued for it. The manufacturer submits a Diphenhydramine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diphenhydramine Hydrochloride CEP holder for the record. Additionally, the data presented in the Diphenhydramine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diphenhydramine Hydrochloride DMF.
A Diphenhydramine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diphenhydramine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diphenhydramine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Diphenhydramine Hydrochloride written confirmation (Diphenhydramine Hydrochloride WC) is an official document issued by a regulatory agency to a Diphenhydramine Hydrochloride manufacturer, verifying that the manufacturing facility of a Diphenhydramine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphenhydramine Hydrochloride APIs or Diphenhydramine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphenhydramine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Diphenhydramine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphenhydramine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diphenhydramine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diphenhydramine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diphenhydramine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphenhydramine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diphenhydramine Hydrochloride suppliers with NDC on PharmaCompass.
Diphenhydramine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diphenhydramine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphenhydramine Hydrochloride GMP manufacturer or Diphenhydramine Hydrochloride GMP API supplier for your needs.
A Diphenhydramine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Diphenhydramine Hydrochloride's compliance with Diphenhydramine Hydrochloride specifications and serves as a tool for batch-level quality control.
Diphenhydramine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Diphenhydramine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diphenhydramine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphenhydramine Hydrochloride EP), Diphenhydramine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphenhydramine Hydrochloride USP).
LOOKING FOR A SUPPLIER?